Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia

Published:2019-08-06 Issue:11 Volume:18 Page:1937-1946
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Zacharias Niki M.,Baran Natalia^ORCID,Shanmugavelandy Sriram S.,Lee Jaehyuk,Lujan Juliana Velez,Dutta Prasanta,Millward Steven W.,Cai Tianyu,Wood Christopher G.,Piwnica-Worms David,Konopleva Marina,Bhattacharya Pratip K.

Funder

HHS | NIH | National Cancer Institute (NCI)

Cancer Prevention and Research Institute of Texas (CPRIT)

UT | University of Texas MD Anderson Cancer Center (MD Anderson)

John S. Dunn Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis;Arthritis Research & Therapy;2023-09-20

2. Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01

3. Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia;Current Treatment Options in Oncology;2023-05-30

4. Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia;Frontiers in Oncology;2023-05-09

5. Enhancing Cancer Diagnosis with Real-Time Feedback: Tumor Metabolism through Hyperpolarized 1-13C Pyruvate MRSI;Metabolites;2023-04-28